​

Qualigen Therapeutics Ownership | Who Owns Qualigen Therapeutics?

OverviewFinancialsChart

Qualigen Therapeutics Ownership Summary

Qualigen Therapeutics is owned by 5.66% institutional investors, and 94.34% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.13% of its assets in Qualigen Therapeutics shares.

QLGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockQualigen Therapeutics5.66%-94.34%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202224-4.00%2,230,7171.96%515.89%5-16.67%2-71.43%
Jun 30, 202225-19.35%2,187,939-19.60%510.03%6-53.85%740.00%
Mar 31, 2022316.90%2,721,2005.35%79.94%13-5-16.67%
Dec 31, 2021293.57%2,583,061-2.19%810.64%1344.44%6-14.29%
Sep 30, 202128-6.67%2,640,78810.15%913.17%9-740.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index36.43K0.13%16.52K
Vanguard Institutional Extnd Mkt Idx Tr22.83K0.08%-
Fidelity Nasdaq Composite Index4.89K0.02%-
SSgA U.S. Extended Market Index Class I4.14K0.02%-
State St US Extended Mkt Indx NL Cl C4.14K0.02%-
Fidelity Series Total Market Index2.92K0.01%-
NT Ext Equity Mkt Idx Fd - L2.11K0.01%-
Northern Trust Extended Eq Market Idx2.11K0.01%-
NT Ext Equity Mkt Idx Fd - NL1.93K0.01%-
SSgA U.S. Total Market Index Strategy1.70K0.01%504.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 22, 2022Poirier Michael S. Chairman and CEOBuy$17.10K
Jun 14, 2022BROIDRICK AMY S. President/CSOBuy$18.60K
Aug 19, 2021Kruger Kurt H-Buy$4.88K
Aug 19, 2021Kruger Kurt H-Buy$4.92K
Apr 26, 2021BROIDRICK AMY S. EVP, Chief Strategy OfficerBuy$9.13K

Insider Transactions Trends

DateBuySell
2022 Q3--
2022 Q22-
2021 Q4--
2021 Q32-
2021 Q23-

QLGN Ownership FAQ

Who Owns Qualigen Therapeutics?

Qualigen Therapeutics shareholders are primarily institutional investors at 5.66%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Qualigen Therapeutics's industry, Biotech Stocks , is 47.04%, which Qualigen Therapeutics falls below.

Does Blackrock own Qualigen Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Qualigen Therapeutics.

Who is the top mutual fund holder of Qualigen Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Qualigen Therapeutics shares, with 0.13% of its total shares outstanding invested in 36.43K Qualigen Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools